Ask AI
ProCE Banner Activity

Taking a New Path: Evaluating Clinical Data With HER2-Targeted ADCs in Genitourinary, Gastrointestinal, and Gynecologic Malignancies – Slides

Slideset

Slides from Zev A. Wainberg, MD; Alexandra Leary, MD, PhD; and Catherine Fahey, MD, PhD, explores the evolving role of HER2-targeted antibody–drug conjugates, including their mechanisms of action and the emerging clinical data across genitourinary, gastrointestinal, and gynecologic cancers.

Released: August 29, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc.